SBA 7(a) / Express for Pharmacy – Educational Overview

What is an SBA 7(a) / Express loan?

The SBA 7(a) loan program is the U.S. Small Business Administration’s flagship lending initiative, designed to help small businesses access capital that conventional bank financing may not cover. Delivered through SBA-approved lenders — including banks, credit unions, and non-bank lenders — the program provides a federal guarantee that encourages lenders to extend financing to qualified businesses that may lack the collateral or track record required for standard commercial loans.

For pharmacy owners, the standard 7(a) loan offers amounts up to $5 million with repayment terms up to 25 years for real estate and 10 years for working capital or equipment. The SBA Express variant is a streamlined version with a faster lender turnaround — typically 36 hours for approval decisions — and a simplified application process, though it is capped at $500,000. Express loans are particularly useful for smaller, time-sensitive needs like equipment upgrades or short-term working capital gaps.

Common uses for SBA 7(a) loans in pharmacies

Pharmacy businesses have unique capital needs — from regulatory compliance costs to specialized dispensing equipment — that make SBA 7(a) loans well-suited. Common uses include:

• Real estate acquisition or refinancing: Purchasing the building housing your pharmacy, refinancing an existing commercial mortgage, or financing leasehold improvements such as build-outs, ADA upgrades, or renovation of dispensing and counseling areas.
• Equipment and technology purchases: Acquiring dispensing automation systems, robotic pill counters, compounding equipment, pharmaceutical refrigeration units, or upgrading point-of-sale and e-prescribing platforms. Equipment financed through a 7(a) loan often carries longer terms than standard equipment loans, which can improve monthly cash flow.
• Working capital and operations: Covering payroll during slow periods, funding inventory replenishment when negotiating with drug wholesalers, managing seasonality (such as flu season surges), or bridging gaps while waiting on insurance reimbursements.
• Pharmacy acquisition: Buying an existing independent pharmacy, acquiring a retiring pharmacist’s book of business, or funding a partner buyout. Goodwill financing — which traditional lenders often decline — is an eligible use under the SBA 7(a) program, making it a common choice for pharmacy acquisitions.
• Debt consolidation: Refinancing multiple higher-rate obligations — merchant cash advances, equipment loans, or lines of credit — into a single SBA loan with a structured repayment schedule and a potentially lower cost of capital.
• Compliance and licensing upgrades: Funding costs associated with HIPAA compliance updates, state board of pharmacy requirements, DEA audit remediation, or specialty pharmacy accreditation (e.g., URAC, ACHC).

Typical eligibility considerations

SBA 7(a) eligibility criteria apply at both the SBA program level and the individual lender level. Requirements vary between lenders, so it helps to understand the common factors underwriters evaluate:

• Business size and industry eligibility: The business must meet the SBA’s definition of a small business. For pharmacies, the SBA typically applies size standards under NAICS code 446110 (Pharmacies and Drug Stores). Most independent pharmacies qualify comfortably as small businesses under these standards.
• Licensing and regulatory compliance: Lenders verify current state pharmacy licensure, DEA registration where applicable, and any specialty pharmacy credentials. An active compliance history without pending violations or license suspensions is important to a lender’s risk assessment.
• Time in business: While the SBA program doesn’t set a minimum, most participating lenders prefer at least two years of operating history for existing pharmacies. Startups or early-stage businesses may still qualify but often face stricter documentation requirements or higher collateral demands.
• Credit profile: Both personal and business credit are reviewed. Personal scores above 650–680 are generally a baseline for most 7(a) lenders, though the specific threshold varies. Business credit history, banking relationships, and any prior derogatory events such as defaults or liens are also considered.
• Cash flow and debt service coverage: The business must demonstrate sufficient net operating income to repay the proposed loan. Lenders typically look for a debt service coverage ratio (DSCR) of 1.25x or higher — meaning business cash flow covers loan payments by at least a 25% margin.
• Collateral and personal guarantees: SBA 7(a) lenders are required to take all available collateral up to the loan amount. This can include pharmacy real estate, equipment, accounts receivable, and personal assets. All owners with 20% or more equity stake are required to provide personal guarantees.
• Eligible use of proceeds: The intended use must align with SBA program rules. Certain purposes are restricted — such as repaying equity investments or financing speculative ventures. Lenders will request documentation showing how funds will be used and verify compliance with SBA standards.

Ready to explore your options? If you’re a pharmacy owner looking for SBA 7(a) financing, reviewing available lenders is a practical first step. Check financing options here to see what may be available for your situation.

Key risks and considerations

SBA 7(a) loans offer favorable terms compared to many alternatives, but they carry real obligations pharmacy owners should evaluate carefully:

• Fixed repayment obligations: Monthly payments are required regardless of business performance. Revenue dips — due to reimbursement rate cuts, loss of a major PBM contract, or seasonal slowdowns — can create cash flow strain if reserves are not maintained.
• Personal liability: Because personal guarantees are required, defaulting on an SBA loan can expose personal assets — including a home, savings, or other property — to collection actions. This is a significant consideration for pharmacy owners who serve as primary guarantors.
• Collateral at risk: If the loan is secured by pharmacy real estate or specialized equipment, default could result in loss of those assets. For owner-occupied pharmacies, this can directly affect operations and continuity of care for patients.
• Pharmacy-specific revenue risks: Changes in drug reimbursement rates, direct and indirect remuneration (DIR) fees from PBMs, shifts in prescription volume, or loss of preferred network status can significantly impact pharmacy revenue — and in turn, the ability to service debt. Borrowers should factor these into their financial projections.
• Processing time and documentation burden: Even with the SBA Express option’s faster turnaround, standard 7(a) loans can take 30–90 days from application to funding. Documentation requirements — including tax returns, financial statements, business plans, and licenses — can be extensive. Working with a lender experienced in pharmacy financing can help reduce delays.
• Loan covenants and operational restrictions: Some lenders impose financial covenants during the loan term — such as minimum DSCR requirements, restrictions on owner distributions, or limits on taking on additional debt — which can affect flexibility in running the business.

Alternative financing options

SBA 7(a) loans are not the only path for pharmacy financing. Depending on the specific need, timeline, and borrower profile, these alternatives may be worth evaluating:

• Conventional bank term loans: Larger, well-established pharmacies with strong financials and substantial collateral may qualify for traditional commercial loans without an SBA guarantee. These often involve less documentation overhead, though underwriting standards are typically stricter.
• SBA 504 / CDC loans: Designed for fixed-asset purchases — particularly owner-occupied commercial real estate and large equipment — the 504 program pairs a bank loan with a Certified Development Company loan, often at competitive long-term fixed rates. A strong alternative when the primary use is real estate or major equipment.
• Equipment financing and leasing: Pharmacy-specific equipment loans or operating leases can be faster to fund and easier to qualify for than a full SBA loan, since the collateral is the equipment itself. Useful for targeted capital expenditures without pledging broader business assets.
• Business lines of credit: Revolving credit facilities work well for managing day-to-day cash flow, seasonal inventory needs, or bridging insurance reimbursement cycles. They are less suited for large capital expenditures but offer flexibility that term loans don’t.
• Invoice and receivables financing: Pharmacies serving nursing homes, long-term care facilities, or billing under specialty programs may carry significant outstanding receivables. Factoring or receivables-based financing can convert those to near-term cash without incurring traditional debt.
• Alternative and non-bank lenders: Non-bank lenders and fintech platforms offer faster underwriting and more flexible eligibility criteria, though typically at higher costs. Useful as a bridge solution or when SBA timelines don’t fit the need — but the total cost of capital should be compared carefully against SBA options.

Find financing for your pharmacy

Understanding your loan options is just the start — connecting with lenders who work with pharmacy businesses is the next step. The link below can help you explore financing providers and options that may fit your needs.

Check financing options for your business →

This content is for informational purposes only and does not constitute financial advice or a loan offer. Loan eligibility, terms, and approval are determined by lenders based on individual review.

Part of our complete guide to SBA loans — compare programs, costs and lender requirements across every industry.